Filing Details

Accession Number:
0001437749-14-011388
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-17 16:46:53
Reporting Period:
2014-06-13
Filing Date:
2014-06-17
Accepted Time:
2014-06-17 16:46:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1484478 Furiex Pharmaceuticals Inc. FURX Pharmaceutical Preparations (2834) 271197863
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1181153 S Paul Covington C/O Furiex Pharmaceuticals, Inc.,
3900 Paramount Parkway, Suite 150
Morrisville NC 27560
Senior Vp-Clinical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-06-13 3,228 $104.25 22,523 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (to buy) $9.11 2020-06-17 45,691 45,691 Direct
Common Stock Stock Options (to buy) $15.00 2021-05-09 26,000 26,000 Direct
Common Stock Stock Options (to buy) $13.16 2021-10-03 37,944 37,944 Direct
Common Stock Stock Options (to buy) $17.80 2022-02-24 10,368 10,368 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2020-06-17 45,691 45,691 Direct
2021-05-09 26,000 26,000 Direct
2021-10-03 37,944 37,944 Direct
2022-02-24 10,368 10,368 Direct
Footnotes
  1. All options became 100% vested on June 11, 2014 in connection with the Agreement and Plan of Merger dated as of April 27, 2014 by and among Forest Laboratories, Inc., Royal Empress, Inc. and Furiex Pharmaceuticals, Inc.